Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

Transplantation · 2010 · 965 citations

Life Sciences, Immunology, Infectious Diseases +17

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Atul Humar, Y Lebranchu, Flavio Vincenti et al. · American Journal of Transplantation · 2010 · 499 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

Atul Humar, Ajit P. Limaye, Emily A. Blumberg et al. · Transplantation · 2010 · 208 citations

Medicine, Immunology, Infectious Diseases +15

Cytomegalovirus UL97 Phosphotransferase Mutations That Affect Susceptibility to Ganciclovir

Sunwen Chou, Rachel H. Waldemer, Anne E. Senters et al. · The Journal of Infectious Diseases · 2002 · 193 citations

Life Sciences, Infectious Diseases, Microbiology +17

Cytomegalovirus Retinitis and Viral Resistance

Douglas A. Jabs, Cheryl Enger, James P. Dunn et al. · The Journal of Infectious Diseases · 1998 · 189 citations · Full text

Medicine, Infectious Diseases, Microbiology +15